Laxmi Organic Allotment: 63,694 ESOP Shares Issued, Capital Grows

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Laxmi Organic Allotment: 63,694 ESOP Shares Issued, Capital Grows
Overview

Laxmi Organic Industries Ltd. has allotted 63,694 equity shares under its ESOP-2020 plan. This move increases the company's total issued share capital to ₹55,44,23,134, representing 27,72,11,567 shares. The newly issued shares rank equally with existing equity and are part of the company's employee compensation and retention strategy.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Laxmi Organic Allotment: 63,694 ESOP Shares Issued, Capital Grows

ESOP Allotment Boosts Share Capital

Laxmi Organic Industries has completed the allotment of 63,694 equity shares under its ESOP-2020 plan. This issuance raises the company's total issued share capital to ₹55.44 crore, marking an increase in its share count. Investors will be watching for any potential dilution effects.

Allotment Details

The filing confirms the issuance of 63,694 equity shares, each with a face value of ₹2. These shares were granted under the company's ESOP-2020 scheme. The exercise prices for these shares varied, ranging from ₹2 to ₹100 per share, with the company collecting a premium on specific tranches of these options.

Strategic Rationale for Employees

This allotment is a strategic initiative by Laxmi Organic Industries aimed at compensating and retaining its employees. By increasing employee ownership, the company seeks to better align their interests with those of shareholders.

Impact on Share Capital and EPS

The allotment has expanded the company's total issued share capital to ₹55,44,23,134, as of April 3, 2026, bringing the total number of outstanding equity shares to 27,72,11,567. This increase in share count will result in a fractional dilution of earnings per share (EPS). The new shares hold the same rights and standing as existing equity shares.

Company Background

Established in 1989, Laxmi Organic Industries is a significant player in the specialty chemicals sector. Its core business segments include Acetyl Intermediates and Speciality Intermediates.

History of Employee Stock Plans

The current ESOP-2020 allotment continues Laxmi Organic's established practice of using stock options as an incentive. Previously, the company allotted 42,692 equity shares under its ESOP in April 2025. Additionally, 429,799 stock options were granted under ESOP-2024 in October 2025.

Peer Landscape

Laxmi Organic Industries operates within the competitive specialty chemicals market. Its industry peers include companies such as Nocil Ltd., Balaji Amines Ltd., and Aether Industries Ltd., all of whom are involved in chemical manufacturing, with a focus on specialty chemicals or related intermediates.

What to Track Next

For investors, key points to monitor include future ESOP exercises by employees and their effect on shareholding patterns. Further announcements regarding additional ESOP grants or exercises will also be significant. Investors will also focus on the company's ongoing performance in its specialty chemical segments and any shareholder reactions to the incremental rise in the share count. Laxmi Organic's continued emphasis on employee retention strategies remains a point of interest.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.